Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial [Corrigendum]

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Clinicoecon Outcomes Res
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove Medical Press 2017
Pynciau:
Corrigendum
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5402876/
https://ncbi.nlm.nih.gov/pubmed/28458569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S138166
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg